
Eropanta-D SR 30mg/40mg Capsule
Marketer
Earum Pharma
Salt Composition
Domperidone (30mg) + Pantoprazole (40mg)
Overview Eropanta-D SR 30mg/40mg Capsule
Gastroesophageal reflux disease (GERD), dyspepsia, and gastritis are effectively managed with the prescription medication, Eropanta-D SR 30mg/40mg Capsules. This medication alleviates symptoms like heartburn, stomach pain, and irritation by decreasing stomach acid production. Furthermore, it neutralizes existing stomach acid and facilitates gas expulsion, minimizing discomfort. Administered on an empty stomach, the dosage and treatment duration are determined by your physician, based on your individual response and condition. Continuous use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common, typically transient, side effects include diarrhea, vomiting, abdominal pain, flatulence, dry mouth, and headache. Report any concerning side effects immediately. Due to potential drowsiness and dizziness, avoid activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided as it may exacerbate drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment efficacy. Prior to commencing treatment, disclose any kidney or liver conditions, as well as pregnancy, pregnancy planning, or breastfeeding status to your doctor.
Primary Ingredients of Eropanta-D SR 30mg/40mg Capsule
No text provided. Please provide the text you would like me to rephrase.
Uses of Eropanta-D SR 30mg/40mg Capsule
Managing gastroesophageal reflux, indigestion, and gastritis.
Major Benefits of Eropanta-D SR 30mg/40mg Capsule:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Eropanta-D SR 30mg/40mg Capsules should be administered on an empty stomach.
Common Side effects of Eropanta-D SR 30mg/40mg Capsule:
- Diarrhea
- Stomach pain
- Flatulence
- Dryness in mouth
- Dizziness
- Headache
How to use Eropanta-D SR 30mg/40mg Capsule:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Administer Eropanta-D SR 30mg/40mg capsules on an empty stomach.
How Eropanta-D SR 30mg/40mg Capsule works:
Eropanta-D SR capsules, containing 30mg Domperidone and 40mg Pantoprazole, combine a prokinetic agent with a proton pump inhibitor. Domperidone stimulates upper gastrointestinal motility, facilitating efficient food passage. Pantoprazole decreases gastric acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Concurrent alcohol use with Eropanta-D SR 30mg/40mg Capsules requires careful consideration. Seek medical advice before combining these.
PregnancyCONSULT YOUR DOCTOR
The use of Eropanta-D SR 30mg/40mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Extended-release Eropanta-D 30mg/40mg capsules require careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Taking Eropanta-D SR 30mg/40mg Capsules may cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Eropanta-D SR 30mg/40mg capsules cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Eropanta-D SR 30mg/40mg Capsules in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Eropanta-D SR 30mg/40mg Capsule :
Should you forget to take your Eropanta-D SR 30mg/40mg Capsule, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eropanta-D SR 30mg/40mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
